Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective

被引：0
|
作者：
O'Nions, Jenny [1 ]
Cowley, Anna [1 ]
Dehbi, Hakim-Moulay [2 ,3 ]
El-Sharkawi, Dima [1 ]
D'Sa, Shirley [4 ]
Ardeshna, Kirit M. [4 ]
Popat, Rakesh [1 ]
Townsend, William [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, NIHR UCLH Clin Res Facil, London, England
[2] UCL, Canc Res UK, London, England
[3] UCL Canc Trials Ctr, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118497
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4227
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Participation in clinical trials to improve outcomes of patients with relapsed lymphoma.
    Nowakowski, Grzegorz S.
    Ansell, Stephen Maxted
    Witzig, Thomas E.
    Macon, William R.
    Ristow, Kay
    Colgan, Joseph
    Inwards, David James
    Johnston, Patrick B.
    Klebig, Robin
    Lin, Yi
    Micallef, Ivana N. M.
    Markovic, Svetomir
    Porrata, Luis F.
    Thompson, Carrie A.
    Habermann, Thomas Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes - Single Institution Experience
    Nowakowski, Grzegorz S.
    Ristow, Kay
    Kurtin, Paul
    Allen, Mark S.
    Micallef, Ivana N.
    Colgan, Joseph
    Inwards, David James
    McPhail, Ellen
    Markovic, Svetomir
    Ansell, Stephen M.
    Porrata, Luis
    Johnston, Patrick B.
    Thompson, Carrie A.
    Witzig, Thomas E.
    Habermann, Thomas M.
    BLOOD, 2010, 116 (21) : 1696 - 1696
  • [33] Outcomes of patients with newly diagnosed light chain amyloidosis according to eligibility for clinical trials: experience of a single institution
    Mateos Perez, Jose Miguel
    Tovar, Natalia
    Tolosa, Carles
    Rodriguez-Lobato, Luis Gerardo
    Fernandez de Larrea, Carlos
    Ortiz, Jose
    Quintana, Luis
    Casals, Joaquim
    Carmen Salgado, M.
    Ignacio Arostegui, Juan
    Moreno, David
    Castillo, Paola
    Llobet, Noemi
    Alejaldre, Aida
    Rosinol, Laura
    Blade, Joan
    Cibeira Lopez, M. Teresa
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S193 - S193
  • [34] Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials
    Sundar, Raghav
    McVeigh, Terri
    Dolling, David
    Petruckevitch, Ann
    Diamantis, Nikolaos
    Ang, Joo Ern
    Chenard-Poirier, Maxime
    Collins, Dearbhaile
    Lim, Joline
    Ameratunga, Malaka
    Khan, Khurum
    Kaye, Stan B.
    Banerji, Udai
    Lopez, Juanita
    George, Angela J.
    de Bono, Johann S.
    van der Graaf, Winette T.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 55 - 61
  • [35] Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010
    Hou, June Y.
    Aparo, Santiago
    Ghalib, Mohammad
    Chaudhary, Imran
    Shah, Umang
    Swami, Umang
    Einstein, Mark
    Goldberg, Gary L.
    Mani, Sridhar
    Goel, Sanjay
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 163 - 168
  • [36] Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials
    How, Jeffrey A.
    Jazaeri, Amir A.
    Fu, Siqing
    Ahnert, Jordi Rodon
    Gong, Jing
    Stephen, Bettzy
    Dalla Pria, Hanna Ferreira
    Bhosale, Priya
    Johnson, Amber
    Yuan, Ying
    Meric-Bernstam, Funda
    Naing, Aung
    CANCERS, 2022, 14 (15)
  • [37] CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH RECURRENT MICROSATELLITE STABLE ENDOMETRIAL CANCER UNDERGOING EARLY PHASE IMMUNOTHERAPY CLINICAL TRIALS
    How, J.
    Jazaeri, A.
    Fu, S.
    Ahnert, J. Rodon
    Gong, J.
    Meric-Bernstam, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A112 - A112
  • [38] Eligibility and outcomes in phase I clinical trials testing targeted therapy, immunotherapy and combinations: A single-institution study
    Marra, A.
    Morganti, S.
    Viale, G.
    Tarantino, P.
    Trapani, D.
    Ferraro, E.
    Zagami, P.
    Repetto, M.
    Nicolo, E.
    D'Amico, P.
    Aliaga, P. Trillo
    Massaro, M. A.
    Busacca, C.
    Minchella, I.
    Belli, C.
    Locatelli, M.
    Mazzarella, L.
    Esposito, A.
    Criscitiello, C.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S13 - S13
  • [39] HEMOPHAGOCYTIC LIMPHOHISTIOCITOSCYS: CLINICAL AND LABORATORY CHARACTERISTICS AND OUTCOMES OF PATIENTS IN A SINGLE INSTITUTION
    Rodrigues, Jessica
    Cypriano, Monica dos Santos
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S26 - S26
  • [40] Clinical outcomes in adult patients with aplastic anemia: A single institution experience
    Boddu, Prajwal
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Jabbour, Elias
    DiNardo, Courtney
    Jain, Nitin
    Daver, Naval
    Pemmaraju, Naveen
    Anderlini, Paolo
    Parmar, Simrit
    Devendra, K. C.
    Akosile, Mary
    Pierce, Sherry A.
    Champlin, Richard
    Cortes, Jorge
    Kantarjian, Hagop
    Kadia, Tapan
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) : 1295 - 1302
12345